The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Michigan seeks input on lowering insulin costs
November 07, 2022
The State of Michigan has issued a Request for Information (RFI) to seek information from potential partners that would aid in lowering the cost insulin for Michiganders. This request is a critical part of Gov. Gretchen Whitmer’s Executive Directive 2022-12 which directs all state agencies to “review aspects of insulin purchasing, distribution, and production within their jurisdictions and identify and assess potential opportunities to lower costs for Michiganders who purchase insulin.”
This RFI will assist state agencies with evaluating options for lowering the cost of insulin, including:
- Development, in conjunction with a partner or partners, of low-cost insulin products for distribution in Michigan
- Production, purchase and/or distribution of low-cost insulin products
- Establishment of a Michigan-based insulin manufacturing facility, including any potential sites for such facility
- Any additional actions that the state could take that would feasibly lower insulin costs for consumers
Businesses or organizations with potential solutions or opportunities to meet these goals are encouraged to submit a response by November 21, 2022, at 3 p.m. The RFI can be viewed on the state’s online procurement portal. Those without an active account can select “Guest Access” in the navigation on the left side of the screen and search for “insulin.” Responses must be sent through the online procurement portal after logging in with a free account. More information about creating an account and can be found at www.michigan.gov/SIGMAVSS.